AM Best Director Joseph Zazzera appears as a guest on an episode of the “Pulse of Prevention” podcast to discuss GLP-1 therapies and implications for insurance companies.

During the episode, Zazzera talks about how GLP-1 therapies have become a driver of pharmacy spending and how health insurers continue to balance the rising pharmacy expenditures with the potential for lower future overall medical costs. Utilization of GLP-1s has significantly accelerated, and for health insurers, this evolution underscores one of the industry’s most significant strategic challenges, as insurers’ pharmacy costs are immediate and measurable, while many of the anticipated benefits of GLP-1 therapies may not be realized for years. Overall, GLP-1s are one of the industry’s most closely watched developments, influencing pharmacy trends, employer and health plan benefit designs, and long-term health care economics. Zazzera has been with AM Best for more than two decades and is responsible for a team of analysts that follow multiline, domestic and international insurers, with a focus on health- and benefits-related segments.

“Pulse of Prevention” is produced by the Insurance Collaboration to Save Lives and is hosted by Mitch Bagley, board member and marketing director. To listen, please visit Pulse of Prevention.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2026 by A.M. Best Company, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Media gallery

About The Author
Business Wire